EP0356128A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
3-(Aminopropyl)methyl phosphinic acid as a therapeutic agent
Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1989-08-16
•
Granted: —
•
Expires: 2009-08-16
Abstract
Abstract The use of 3-(aminopropyl)methyl phosphinic acid as a potent selective GABAB receptor agonist, pharmaceutical compositions containing it, and its use in therapy, in particular in the treatment of central nervous system disorders.
Inventors
- 👤 Judith Mary Hills
- 👤 William Howson
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-02 14:42
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/5537; A; A61; A61K; A61K31/00; A61K31/66; A61P; A61P25/00; C07F9/28; C07F9/30; C07F9/301
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
26 words
A process for preparing a pharmaceutical composition which comprises bringing into association 3-(aminopropyl)methyl phosphinic acid or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
Claim 2
Dependent Claim
26 words
A process for preparing a pharmaceutical composition which comprises bringing into association 3-(aminopropyl)methyl phosphinic acid or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
28 words
The use of 3-(aminopropyl)methyl phosphinic acid or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of disorders of the central nervous system.
Claim 4
Dependent Claim
28 words
The use of 3-(aminopropyl)methyl phosphinic acid or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of disorders of the central nervous system.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.